Temp Sr. Research Associate DMPK
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
-
Develop LC-MS/MS methods and analyze in vivo and in vitro samples to support ADME, pharmacokinetic, and toxicokinetic studies, etc.
-
Handle a variety of tissues, including tumors, from tissue homogenization through sample preparation for bioanalysis.
-
Perform data analysis, prepare experimental result reports, and upload data to electronic notebooks.
